A Study to Assess the Safety, Tolerability and Efficacy of OP0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months

NCT03818815 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Otitis Media

Interventions

COMBINATION_PRODUCT: OP0201
COMBINATION_PRODUCT: Placebo
DRUG: Amoxicillin-clavulanate

Sponsor

Novus Therapeutics, Inc